Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Physiol Rep ; 6(2)2018 01.
Article in English | MEDLINE | ID: mdl-29368802

ABSTRACT

Maximal neuromuscular power is an important determinant of athletic performance and also quality of life, independence, and perhaps even mortality in patient populations. We have shown that dietary nitrate (NO3- ), a source of nitric oxide (NO), improves muscle power in some, but not all, subjects. The present investigation was designed to identify factors contributing to this interindividual variability. Healthy men (n = 13) and women (n = 7) 22-79 year of age and weighing 52.1-114.9 kg were studied using a randomized, double-blind, placebo-controlled, crossover design. Subjects were tested 2 h after ingesting beetroot juice (BRJ) either containing or devoid of 12.3 ± 0.8 mmol of NO3- . Plasma NO3- and nitrite (NO2- ) were measured as indicators of NO bioavailability and maximal knee extensor speed (Vmax ), power (Pmax ), and fatigability were determined via isokinetic dynamometry. On average, dietary NO3- increased (P < 0.05) Pmax by 4.4 ± 8.1%. Individual changes, however, ranged from -9.6 to +26.8%. This interindividual variability was not significantly correlated with age, body mass (inverse of NO3- dose per kg), body mass index (surrogate for body composition) or placebo trial Vmax or fatigue index (in vivo indicators of muscle fiber type distribution). In contrast, the relative increase in Pmax was significantly correlated (r = 0.60; P < 0.01) with the relative increase in plasma NO2- concentration. In multivariable analysis female sex also tended (P = 0.08) to be associated with a greater increase in Pmax. We conclude that the magnitude of the dietary NO3- -induced increase in muscle power is dependent upon the magnitude of the resulting increase in plasma NO2- and possibly female sex.


Subject(s)
Athletic Performance/physiology , Beta vulgaris , Muscle Fibers, Skeletal/physiology , Nitrates/administration & dosage , Adult , Aged , Cross-Over Studies , Dietary Supplements , Double-Blind Method , Female , Fruit and Vegetable Juices , Humans , Male , Middle Aged , Nitrates/blood , Nitric Oxide/blood , Plant Roots , Young Adult
2.
J Card Fail ; 24(2): 65-73, 2018 02.
Article in English | MEDLINE | ID: mdl-28916479

ABSTRACT

BACKGROUND: Patients with heart failure with reduced ejection fraction (HFrEF) exhibit lower efficiency, dyspnea, and diminished peak oxygen uptake (VO2peak) during exercise. Dietary nitrate (NO3-), a source of nitric oxide (NO), has improved these measures in some studies of other populations. We determined the effects of acute NO3- ingestion on exercise responses in 8 patients with HFrEF using a randomized, double-blind, placebo-controlled, crossover design. METHODS AND RESULTS: Plasma NO3-, nitrite (NO2-), and breath NO were measured at multiple time points and respiratory gas exchange was determined during exercise after ingestion of beetroot juice containing or devoid of 11.2 mmol of NO3-. NO3- intake increased (P < .05-0.001) plasma NO3- and NO2- and breath NO by 1469 ± 245%, 105 ± 34%, and 60 ± 18%, respectively. Efficiency and ventilation during exercise were unchanged. However, NO3- ingestion increased (P < .05) VO2peak by 8 ± 2% (ie, from 21.4 ± 2.1 to 23.0 ± 2.3 mL.min-1.kg-1). Time to fatigue improved (P < .05) by 7 ± 3 % (ie, from 582 ± 84 to 612 ± 81 seconds). CONCLUSIONS: Acute dietary NO3- intake increases VO2peak and performance in patients with HFrEF. These data, in conjunction with our recent data demonstrating that dietary NO3- also improves muscle contractile function, suggest that dietary NO3- supplementation may be a valuable means of enhancing exercise capacity in this population.


Subject(s)
Dietary Supplements , Exercise Tolerance/physiology , Heart Failure/therapy , Nitrites/pharmacology , Oxygen Consumption/physiology , Oxygen/blood , Respiration/drug effects , Stroke Volume/physiology , Cross-Over Studies , Double-Blind Method , Female , Follow-Up Studies , Heart Failure/blood , Heart Failure/physiopathology , Humans , Male , Middle Aged
3.
J Nucl Cardiol ; 24(4): 1226-1235, 2017 08.
Article in English | MEDLINE | ID: mdl-27048307

ABSTRACT

BACKGROUND: In animal models of heart failure (HF), myocardial metabolism shifts from high-energy fatty acid (FA) metabolism toward glucose. However, FA (vs glucose) metabolism generates more ATP/mole; thus, FA metabolism may be especially advantageous in HF. Sex modulates myocardial blood flow (MBF) and substrate metabolism in normal humans. Whether sex affects MBF and metabolism in patients with HF is unknown. METHODS AND RESULTS: We studied 19 well-matched men and women with nonischemic HF (EF ≤ 35%). MBF and myocardial substrate metabolism were quantified using positron emission tomography. Women had higher MBF (mL/g/minute), FA uptake (mL/g/minute), and FA utilization (nmol/g/minute) (P < 0.005, P < 0.005, P < 0.05, respectively) and trended toward having higher FA oxidation than men (P = 0.09). These findings were independent of age, obesity, and insulin resistance. There were no sex-related differences in fasting myocardial glucose uptake or metabolism. Higher MBF was related to improved event-free survival (HR 0.31, P = 0.02). CONCLUSIONS: In nonischemic HF, women have higher MBF and FA uptake and metabolism than men, irrespective of age, obesity, or insulin resistance. Moreover, higher MBF portends a better prognosis. These sex-related differences should be taken into account in the development and targeting of novel agents aimed at modulating MBF and metabolism in HF.


Subject(s)
Coronary Circulation , Fatty Acids/metabolism , Heart Failure/metabolism , Adult , Female , Humans , Male , Prospective Studies , Sex Characteristics
4.
JACC Cardiovasc Imaging ; 9(5): 603-17, 2016 05.
Article in English | MEDLINE | ID: mdl-27151523

ABSTRACT

Myocarditis is a recognized but underdiagnosed cause of cardiomyopathy due to its wide clinical spectrum and nonspecific presentation. Accurate diagnosis is important because 25% of patients with acute myocarditis develop cardiomyopathy, and of those, approximately 5% per year require heart transplantation or die. Current guidelines for the recognition and treatment of the inflammatory cardiomyopathies are limited. The gold standard for diagnosis, endomyocardial biopsy, has low sensitivity, and thus, multimodality imaging of inflammation plays a crucial role in defining the cardiac abnormalities and in assisting with diagnosis and management. The literature on inflammatory cardiomyopathies is limited to small studies of selected populations due to the diverse etiologies and inherent difficulties in definitive diagnosis. This review focuses on the current and projected use of various imaging modalities, including echocardiography, cardiac magnetic resonance, and nuclear imaging to better define inflammatory cardiomyopathies and aid in their management; it specifically focuses on cardiac sarcoidosis, and giant cell, eosinophilic, and lymphocytic myocarditis.


Subject(s)
Cardiac Imaging Techniques , Cardiomyopathies/diagnostic imaging , Myocarditis/diagnostic imaging , Cardiomyopathies/etiology , Cardiomyopathies/therapy , Humans , Myocarditis/complications , Myocarditis/therapy , Predictive Value of Tests , Prognosis , Reproducibility of Results , Risk Factors
6.
J Am Soc Echocardiogr ; 29(3): 195-204, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26687690

ABSTRACT

BACKGROUND: The recent report that appropriately performed echocardiographic examinations result in active changes in management in only one third of patients has challenged the validity of current appropriate use criteria. Limited information exists about the clinical importance of transthoracic echocardiography (TTE) to guide management and rule out important alternative pathology. METHODS: The clinical impact of inpatient TTE performed at the Mayo Clinic over a 20-week period between October 14, 2013, and March 3, 2014, was investigated. Studies were included if they were ordered within 72 hours of admission, and treating physicians participated in a real-time survey regarding the clinical importance of TTE. Appropriate use was determined by two independent investigators, with differences adjudicated by a third investigator. Clinical impact was derived from physicians' survey responses and independently confirmed by chart review. RESULTS: Of the 539 transthoracic echocardiographic examinations included in this study, 512 (95%) were appropriate, 16 (3%) may be appropriate and 11 (2%) rarely appropriate. Although only 48% of participating physicians actively changed management on the basis of findings on TTE, 97% responded that TTE answered their clinical questions, and 95% would still order TTE in similar clinical contexts. CONCLUSIONS: Most early inpatient transthoracic echocardiographic studies at our institution were appropriate and answered specific clinical questions important for management decisions in the opinion of the treating physician. Confirming a plan of care already in place and ruling out alternative pathology may be as important clinically as uncovering new findings or changing management.


Subject(s)
Attitude of Health Personnel , Echocardiography/statistics & numerical data , Heart Diseases/diagnostic imaging , Heart Diseases/epidemiology , Medical Overuse/statistics & numerical data , Physicians/statistics & numerical data , Aged , Female , Humans , Male , Medical Overuse/prevention & control , Minnesota/epidemiology , Observer Variation , Reproducibility of Results , Sensitivity and Specificity , Utilization Review
7.
Circ Heart Fail ; 8(5): 914-20, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26179185

ABSTRACT

BACKGROUND: Skeletal muscle strength, velocity, and power are markedly reduced in patients with heart failure, which contributes to their impaired exercise capacity and lower quality of life. This muscle dysfunction may be partially because of decreased nitric oxide (NO) bioavailability. We therefore sought to determine whether ingestion of inorganic nitrate (NO3 (-)) would increase NO production and improve muscle function in patients with heart failure because of systolic dysfunction. METHODS AND RESULTS: Using a double-blind, placebo-controlled, randomized crossover design, we determined the effects of dietary NO3 (-) in 9 patients with heart failure. After fasting overnight, subjects drank beetroot juice containing or devoid of 11.2 mmol of NO3 (-). Two hours later, muscle function was assessed using isokinetic dynamometry. Dietary NO3 (-) increased (P<0.05-0.001) breath NO by 35% to 50%. This was accompanied by 9% (P=0.07) and 11% (P<0.05) increases in peak knee extensor power at the 2 highest movement velocities tested (ie, 4.71 and 6.28 rad/s). Maximal power (calculated by fitting peak power data with a parabola) was therefore greater (ie, 4.74±0.41 versus 4.20±0.33 W/kg; P<0.05) after dietary NO3 (-) intake. Calculated maximal velocity of knee extension was also higher after NO3 (-) ingestion (ie, 12.48±0.95 versus 11.11±0.53 rad/s; P<0.05). Blood pressure was unchanged, and no adverse clinical events occurred. CONCLUSIONS: In this pilot study, acute dietary NO3 (-) intake was well tolerated and enhanced NO bioavailability and muscle power in patients with systolic heart failure. Larger-scale studies should be conducted to determine whether the latter translates into an improved quality of life in this population. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01682356.


Subject(s)
Dietary Supplements , Exercise/physiology , Heart Failure/diet therapy , Muscle Contraction/drug effects , Muscle, Skeletal/physiopathology , Nitrates/administration & dosage , Cross-Over Studies , Dose-Response Relationship, Drug , Double-Blind Method , Female , Heart Failure/physiopathology , Humans , Male , Middle Aged , Muscle, Skeletal/drug effects , Oxygen Consumption , Pilot Projects , Quality of Life
8.
Nitric Oxide ; 48: 16-21, 2015 Aug 01.
Article in English | MEDLINE | ID: mdl-25199856

ABSTRACT

Nitric oxide (NO) has been demonstrated to enhance the maximal shortening velocity and maximal power of rodent muscle. Dietary nitrate (NO3(-)) intake has been demonstrated to increase NO bioavailability in humans. We therefore hypothesized that acute dietary NO3(-) intake (in the form of a concentrated beetroot juice (BRJ) supplement) would improve muscle speed and power in humans. To test this hypothesis, healthy men and women (n = 12; age = 22-50 y) were studied using a randomized, double-blind, placebo-controlled crossover design. After an overnight fast, subjects ingested 140 mL of BRJ either containing or devoid of 11.2 mmol of NO3(-). After 2 h, knee extensor contractile function was assessed using a Biodex 4 isokinetic dynamometer. Breath NO levels were also measured periodically using a Niox Mino analyzer as a biomarker of whole-body NO production. No significant changes in breath NO were observed in the placebo trial, whereas breath NO rose by 61% (P < 0.001; effect size = 1.19) after dietary NO3(-) intake. This was accompanied by a 4% (P < 0.01; effect size = 0.74) increase in peak knee extensor power at the highest angular velocity tested (i.e., 6.28 rad/s). Calculated maximal knee extensor power was therefore greater (i.e., 7.90 ± 0.59 vs. 7.44 ± 0.53 W/kg; P < 0.05; effect size = 0.63) after dietary NO3(-) intake, as was the calculated maximal velocity (i.e., 14.5 ± 0.9 vs. 13.1 ± 0.8 rad/s; P < 0.05; effect size = 0.67). No differences in muscle function were observed during 50 consecutive knee extensions performed at 3.14 rad/s. We conclude that acute dietary NO3(-) intake increases whole-body NO production and muscle speed and power in healthy men and women.


Subject(s)
Knee Joint/physiology , Muscle, Skeletal/physiology , Nitrates/pharmacology , Adult , Biological Availability , Dietary Supplements , Female , Humans , Knee Joint/drug effects , Male , Middle Aged , Muscle Contraction/drug effects , Muscle Fatigue/physiology , Muscle Strength/physiology , Nitrates/administration & dosage , Nitric Oxide/pharmacokinetics , Torque , Young Adult
9.
Heart Fail Rev ; 18(5): 567-74, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23180281

ABSTRACT

Myocardial substrate metabolism provides the energy needed for cardiac contraction and relaxation. The normal adult heart uses predominantly fatty acids (FAs) as its primary fuel source. However, the heart can switch and use glucose (and to a lesser extent, ketones, lactate, as well as endogenous triglycerides and glycogen), depending on the metabolic milieu and superimposed conditions. FAs are not a wholly better fuel than glucose, but they do provide more energy per mole than glucose. Conversely, glucose is the more oxygen-efficient fuel. Studies in animal models of heart failure (HF) fairly consistently demonstrate a shift away from myocardial fatty acid metabolism and toward glucose metabolism. Studies in humans are less consistent. Some show the same metabolic switch away from FA metabolism but not all. This may be due to differences in the etiology of HF, sex-related differences, or other mitigating factors. For example, obesity, insulin resistance, and diabetes are all related to an increased risk of HF and may complicate or contribute to its development. However, these conditions are associated with increased FA metabolism. This review will discuss aspects of human heart metabolism in systolic dysfunction as measured by the noninvasive, quantitative method-positron emission tomography. Continued research in this area is vital if we are to ameliorate HF by manipulating heart metabolism with the aim of increasing energy production and/or efficiency.


Subject(s)
Energy Metabolism , Fatty Acids/metabolism , Glucose/metabolism , Heart Failure, Systolic/diagnostic imaging , Myocardium/metabolism , Positron-Emission Tomography , Heart Failure, Systolic/metabolism , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...